Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (716K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Paulin, F.
Right arrow Articles by Willis, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paulin, F.
Right arrow Articles by Willis, A. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, Vol 26, Issue 13 3097-3103, Copyright © 1998 by Oxford University Press


ARTICLES

A single nucleotide change in the c-myc internal ribosome entry segment leads to enhanced binding of a group of protein factors

FEM Paulin, SA Chappell and AE Willis
Department of Biochemistry, University of Leicester, University Road, Leicester LE1 7RH, UK.

A 340 nucleotide section of the c- myc 5' untranslated region (UTR) contains an internal ribosome entry segment. We have described previously a mutation in this region of RNA in cell lines derived from patients with multiple myeloma (MM) which exhibit increased expression of c- myc protein by an aberrant translational mechanism. In this study we show by electrophoretic mobility shift assays (EMSA), north-western blotting and UV cross-linking that radiolabelled c- myc 5' UTR RNA transcripts which harbour the mutation cause enhanced binding of cellular proteins. In addition, we also demonstrate that an MM derived cell line possesses an altered repertoire of RNA binding proteins. Our data suggest that the deregulated expression of c -myc in MM could result both from the effect of the mutation and the additional proteins which are present in these cell types.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
L. C. Cobbold, K. A. Spriggs, S. J. Haines, H. C. Dobbyn, C. Hayes, C. H. de Moor, K. S. Lilley, M. Bushell, and A. E. Willis
Identification of Internal Ribosome Entry Segment (IRES)-trans-Acting Factors for the Myc Family of IRESs
Mol. Cell. Biol., January 1, 2008; 28(1): 40 - 49.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. A. Chappell and V. P. Mauro
The Internal Ribosome Entry Site (IRES) Contained within the RNA-binding Motif Protein 3 (Rbm3) mRNA Is Composed of Functionally Distinct Elements
J. Biol. Chem., September 5, 2003; 278(36): 33793 - 33800.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I-M. Siu, A. Lal, J. R. Blankenship, N. Aldosari, and G. J. Riggins
c-Myc Promoter Activation in Medulloblastoma
Cancer Res., August 15, 2003; 63(16): 4773 - 4776.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
C. U.T. Hellen and P. Sarnow
Internal ribosome entry sites in eukaryotic mRNA molecules
Genes & Dev., July 1, 2001; 15(13): 1593 - 1612.
[Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Stoneley, T. Subkhankulova, J. P. C. Le Quesne, M. J. Coldwell, C. L. Jopling, G. J. Belsham, and A. E. Willis
Analysis of the c-myc IRES; a potential role for cell-type specific trans-acting factors and the nuclear compartment
Nucleic Acids Res., February 1, 2000; 28(3): 687 - 694.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.